Mercado Global de Nanomedicina para Administração de Medicamentos – Tendências do Setor e Previsão para 2028

Análise de mercado e insights de nanomedicina para a administração de fármacos

The nanomedicine for drug delivery market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 431.33 billion by 2028 and will grow at a CAGR of 11.87% in the above mentioned forecast período.

A nanomedicina é um ramo da medicina que utiliza ferramentas e conhecimentos da nanotecnologia para evitar e tratar diversas doenças. Os nanomedicamentos são medicamentos multifuncionais com propriedades programáveis ​​e encontram a sua aplicação na construção, monitorização, reparação e controlo de sistemas biológicos a nível molecular com o auxílio de nanopartículas e nanodispositivos.

A elevada procura no tratamento de doenças neurológicas está entre os fatores importantes que deverão intensificar o crescimento e a procura da nanomedicina para o mercado de distribuição de medicamentos. Além disso, também se espera que a absorção insuficiente da administração oral de medicamentos em condições neurológicas, como a doença de Parkinson, a doença de Alzheimer e o tumor, contribua para o crescimento do mercado global durante o período previsto de 2021 a 2028. Também o rápido aumento da procura de nanopartículas de ouro, lipídicas ou biodegradáveis ​​para o tratamento de distúrbios complexos do SNC e a elevada adoção de nanopartículas lipossomais para encapsular agentes terapêuticos também deverão aumentar o crescimento do mercado. Além disso, a introdução de avanços tecnológicos nos procedimentos de diagnóstico e o aumento da utilização da nanomedicina na tecnologia de distribuição de fármacos são também um dos fatores significativos que deverão alimentar o crescimento do mercado da nanomedicina para distribuição de fármacos.                         

Prevê-se que a introdução de tecnologia e potencial pipeline de produtos baseados em nanomoléculas, o aumento do nível de participação governamental no financiamento de I&D e o surgimento de nanorobótica ofereçam oportunidades de crescimento significativas para o mercado no período de previsão de 2021 a 2028.

However, the strict regulatory guidelines and long approval process are expected to curb the growth of the nanomedicine for drug delivery market, whereas the nanomedicine based devices involves huge investment which can challenge the growth of the nanomedicine for drug delivery market.

This nanomedicine for drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nanomedicine for drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Nanomedicine for Drug Delivery Market Scope and Market Size

The nanomedicine for drug delivery market is segmented on the basis of modality, product type and indication. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of modality, the nanomedicine for drug delivery market is segmented into diagnostics and treatments.
• On the basis of product type, the nanomedicine for drug delivery market is segmented into nanoparticles, nano-shells, nanotubes and nanodevices. Nanoparticles have further been segmented into metal and metal oxide nanoparticles, liposomes, polymers & polymer drug conjugates, hydrogel nanoparticles, dendrimers and inorganic nanoparticles.

The indication segment of nanomedicine for drug delivery market is segmented into oncological diseases, infectious diseases, cardiovascular diseases, orthopedic disorders, neurological diseases, urological diseases, ophthalmological diseases, immunological diseases and others.

 Nanomedicine for Drug Delivery Market Country Level Analysis

The nanomedicine for drug delivery market is analyzed and market size insights and trends are provided by country, modality, product type and indication as referenced above.

The countries covered in the nanomedicine for drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the nanomedicine for drug delivery market owing to the strong presence of increasingly growing partnerships among enterprises operating herein and nanomedicine startup organizations. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the increase in number of research grants and rise in demand for prophylaxis of life-threatening diseases.

The country section of the nanomedicine for drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The nanomedicine for drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nanomedicine for drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nanomedicine for drug delivery market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Nanomedicine for Drug Delivery Market Share Analysis

The nanomedicine for drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to nanomedicine for drug delivery market.

Os principais players abordados no relatório do mercado de nanomedicina para administração de fármacos são Abbott, Amgen Foundation, Inc., AstraZeneca, Cadila Pharmaceuticals., Celgene Corporation, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Gilead Sciences, Inc. ., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited., Sanofi, Bristol-Myers Squibb Company, Luminex Corporation, Eli Lilly and Company, Ablynx NV, Merck & Co., Inc., Nanospectra Biosciences , Inc. e Nanobiotix entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a Global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul em separado. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-61763